Roquefort Therapeutics buys UK biotech in return for shares
Medical biotechnology company, Roquefort Therapeutics, has conditionally agreed to buy UK biotech Oncogeni Ltd in…
22/06/2022 - 2 minutes
News and Trends
Millions invested for progression of Lyme disease vaccine
Pfizer has agreed to invest €90.5 million ($95 million) towards a vaccination for Lyme disease. …
22/06/2022 - 2 minutes
US Toddlers and children to receive Covid-19 vaccine after emergency approval granted
Emergency authorization was granted for the use of the Pfizer-BioNTech Covid-19 vaccines on children from…
22/06/2022 - 3 minutes
Rensselaer researchers make face masks to fight viruses
Researchers at Rensselaer Polytechnic Institute in Troy, NY, have developed N95 surgical face masks that…
22/06/2022 - 3 minutes
Cystic fibrosis in the crosshairs as Carbon Biosciences launches with $38M funding
Carbon Biosciences, a Longwood Fund founded biotech company developing parvovirus-derived gene therapies, has launched with…
22/06/2022 - 3 minutes
From mugwort allergy to an effective vaccine?
A research team at MedUni Vienna in Austria says it has discovered key mechanisms of…
22/06/2022 - 2 minutes
Galapagos to acquire CellPoint and AboundBio to advance cell therapies
Belgian headquartered biotech Galapagos NV has acquired CellPoint and AboundBio, a move the Belgian company…
22/06/2022 - 5 minutes
Drug to treat esophageal cancer approved in China
A new drug application for first-line treatment of unresectable, locally advanced, recurrent or metastatic esophageal…
21/06/2022 - 2 minutes
New data demonstrates clinical potential of Inivata’s RaDaR technology for breast cancer
Data supporting the detection of minimal residual disease (MRD) has highlighted potential to provide an…
21/06/2022 - 3 minutes
Treatment for highly-sensitized kidney transplant patients approved and recommended
Treatment offered by Hansa Biopharma for the densensitization of highly sensitized adults prior to kidney…
21/06/2022 - 3 minutes
Therorna funding to accelerate circRNA-based platform
Therorna Inc., a Chinese biotech company specializing in the development of circular RNA (circRNA) technology-based…
21/06/2022 - 2 minutes
Elypta raises $21M to develop early detection test for all cancers
Elypta, a Swedish diagnostics company aiming to commercialize the first metabolism-based liquid biopsy for early…
21/06/2022 - 2 minutes
